BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24953125)

  • 1. Pharmacoeconomics in the years of crisis: a solution or just a resolution? A Cyprus perspective.
    Petrou P
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):627-36. PubMed ID: 24953125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyprus in crisis: Recent changes in the pharmaceutical market and options for further reforms without sacrificing access to or quality of treatment.
    Petrou P; Vandoros S
    Health Policy; 2015 May; 119(5):563-8. PubMed ID: 25837234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Healthcare reforms in Cyprus 2013-2017: Does the crisis mark the end of the healthcare sector as we know it?
    Petrou P; Vandoros S
    Health Policy; 2018 Feb; 122(2):75-80. PubMed ID: 29274916
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crisis as a serendipity for change in Cyprus' healthcare services.
    Petrou P
    J Med Econ; 2015; 18(10):805-7. PubMed ID: 25958947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Ariadne's thread in co-payment, primary health care usage and financial crisis: findings from Cyprus public health care sector.
    Petrou P
    Public Health; 2015 Nov; 129(11):1503-9. PubMed ID: 26395291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reforms in the Greek pharmaceutical market during the financial crisis.
    Vandoros S; Stargardt T
    Health Policy; 2013 Jan; 109(1):1-6. PubMed ID: 22959163
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moving forward: lessons for Cyprus as it implements its health insurance scheme.
    Cylus J; Papanicolas I; Constantinou E; Theodorou M
    Health Policy; 2013 Apr; 110(1):1-5. PubMed ID: 23295160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Impact of Financial Crisis, Austerity Measures, and Bailout Agreement on Cypriots' Health: The Memorandum Is Dead, Long Live the Memorandum.
    Petrou P
    Value Health Reg Issues; 2019 Sep; 19():99-103. PubMed ID: 31377656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of quality on the demand for outpatient services in Cyprus.
    Hanson K; Yip WC; Hsiao W
    Health Econ; 2004 Dec; 13(12):1167-80. PubMed ID: 15386672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacoeconomic picture in Saudi Arabia.
    Alkhenizan A
    Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):483-90. PubMed ID: 24953076
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Industry perspectives: ensuring vaccination of children and adolescents without financial barriers.
    Feinberg MB; Gordon L
    Pediatrics; 2009 Dec; 124 Suppl 5():S563-4. PubMed ID: 19948589
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyprus health system review.
    Theodorou M; Charalambous C; Petrou C; Cylus J
    Health Syst Transit; 2012; 14(6):1-128. PubMed ID: 23149260
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systems for the provision of oral health care in the black sea countries part 13: cyprus.
    Charalambous C; Theodorou M
    Oral Health Dent Manag; 2013 Mar; 12(1):3-8. PubMed ID: 23474575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost containment in the Australian Health Care System--an unexpected success.
    Deeble JS; Smith LR
    Cah Sociol Demogr Med; 2000; 40(1):95-112. PubMed ID: 10965433
    [No Abstract]   [Full Text] [Related]  

  • 15. Transitioning to a national health system in Cyprus: a stakeholder analysis of pharmaceutical policy reform.
    Wouters OJ; Kanavos PG
    Bull World Health Organ; 2015 Sep; 93(9):606-13. PubMed ID: 26478624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. When do developing countries adopt managed care policies and technologies? Part I: Policies, experience, and a framework of preconditions.
    Peabody JW; Luck J
    Am J Manag Care; 2002 Nov; 8(11):997-1007. PubMed ID: 12437314
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Implications of the development of managed health care in the South African private health care sector.
    Kinghorn AW
    S Afr Med J; 1996 Apr; 86(4):335-8. PubMed ID: 8693366
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Greek's health, waiting for the 'deus ex machina'.
    Fanourgiakis J; Kanoupakis E
    Expert Rev Pharmacoecon Outcomes Res; 2014 Oct; 14(5):637-42. PubMed ID: 24902711
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A decade of growth in public and private pharmaceutical expenditures: the case of Belgium 1990-1999.
    Vander Stichele RH; Peys F; Van Tielen R; Van Eeckhout H; van Essche O; Seys B
    Acta Clin Belg; 2003; 58(5):279-89; discussion 277-8. PubMed ID: 14748094
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Greek economic crisis and health care reforms: correcting the wrong prescription.
    Niakas D
    Int J Health Serv; 2013; 43(4):597-602. PubMed ID: 24397229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.